UnitedHealth Group (NYSE:UNH) Trading Down 2.8% – Here’s What Happened

UnitedHealth Group Incorporated (NYSE:UNH) dropped 2.8% during trading on Thursday . The stock traded as low as $276.29 and last traded at $277.2880. Approximately 10,347,432 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 9,916,084 shares. The stock had previously closed at $285.25.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: U.S. Senator Markwayne Mullin reported buying $50k–$100k of UNH shares on Feb. 25, a high-profile insider purchase that can be read as a modest vote of confidence. Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Here’s What He Bought And Sold
• Positive Sentiment: UNH showed intraday resilience in recent sessions, advancing while the broader market dipped, suggesting relative strength versus peers on some trading days. UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
• Positive Sentiment: Weakness at Centene (a large peer) over ACA exposure may reallocate investor attention toward more diversified insurers like UNH, a potential relative benefit if concerns remain concentrated at competitors. Centene Is the Worst S&P 500 Stock Today. What’s Ailing the Health Insurer.
• Neutral Sentiment: Management presented at Barclays’ Global Healthcare conference; the transcript provides detail on strategy and execution but contains no clear new guidance that would meaningfully move the stock alone. UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• Neutral Sentiment: Recent analyst reports and stock forecasts are circulating but show a range of views — keep an eye on guidance and consensus revisions for a clearer directional signal. UnitedHealth Group Incorporated (UNH) Stock Forecasts
• Negative Sentiment: Several pieces highlight recent share-price weakness and negative total returns year-to-date and over the past year, raising valuation concerns that can pressure the stock. A Look At UnitedHealth Group’s Valuation After Recent Share Price Weakness
• Negative Sentiment: Sector headwinds — rising medical costs, nursing shortages and reimbursement pressures — remain a recurring theme in coverage and could weigh on margins and sentiment for HMO/insurer stocks. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage
• Negative Sentiment: Some outlets flagged the Mullin purchase as “suspicious” (timing/filing questions), which could create short-term headlines and investor nervousness despite being a disclosed trade. U.S. senator Markwayne Mullin just made a super suspicious stock trade

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Barclays cut their price objective on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a research note on Friday, January 30th. Leerink Partners dropped their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research report on Friday, January 23rd. Finally, Mizuho lowered their target price on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Down 2.8%

The company has a market cap of $251.69 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 1.30 and a beta of 0.41. The business’s fifty day moving average is $305.51 and its two-hundred day moving average is $325.43. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the prior year, the company earned $6.81 EPS. The business’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.2%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s payout ratio is 67.02%.

Institutional Trading of UnitedHealth Group

Several large investors have recently bought and sold shares of the stock. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group during the 4th quarter worth about $25,000. Beacon Financial Strategies CORP acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $26,000. Anfield Capital Management LLC boosted its position in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth $27,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.